Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
08/2007
08/16/2007US20070191410 Cyclopamine analogues and methods of use thereof
08/16/2007US20070191379 ABCA1 elevating compounds
08/16/2007US20070191373 Heterocyclic compounds for use in the treatment of viral infections
08/16/2007US20070191339 Crystalline forms of a pharmaceutical compound
08/16/2007US20070191334 Tricyclic imidazopyridines
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds
08/16/2007CA2640652A1 Novel coumarin derivative having antitumor activity
08/15/2007EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors
08/15/2007EP1817288A1 Dual antiplatelet/anticoagulant pyridoxine analogs
08/15/2007EP1817036A2 Modulators of muscarinic receptors
08/15/2007EP1534715B1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders
08/15/2007EP1458724B1 Total synthesis of galanthamine, analogues and derivatives thereof
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/14/2007US7256293 Imidazopyridine intermediates
08/14/2007US7256187 E.g., 11-Dideoxy-4,11-dihydroxyiminorifamycin S and (R/S)-3-[4-(3-Carboxy-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinolin-7-yl)-2-methyl-piperazin-1-yl-aminomethylenyl]-11-deoxy-11-hydroxyiminorifamycin SV; especially effective against rifamycin-resistant microbes
08/14/2007US7256158 Animal husbandry; veterinary medicine
08/09/2007WO2007089683A1 Amido compounds and their use as pharmaceuticals
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088462A1 Spirochromane antagonists of the h-3 receptor
08/09/2007WO2007088148A1 Derivatives of thiophene carboxilic acid as antiviral agent
08/09/2007US20070185153 Compounds
08/09/2007US20070185144 N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((4S)-2,6,6-trimethyl-4,5,6,7-tetrahydro-1-benzofuran-4yl)amino)propyl)acetamide, used for the treatment of Alzheimer's disease and conditions involving amyloid deposits on the brain
08/09/2007US20070185131 Heterocyclic Compounds
08/09/2007US20070185120 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
08/09/2007US20070185104 Benzoxazole acetonitriles
08/09/2007US20070185098 antiinflammatory agents, anticarcinogenic agents; 1-(5-tert-Butyl-3-(thiomorpholine-1,1-dioxide-4-carbonyl)thiophen-2-yl)-3-(3',4'-difluoro[1,1'-biphenyl]urea; enzyme inhibitors
08/09/2007US20070185094 Novel 3-substitued-1,4-benzodiazepines
08/09/2007US20070185087 Compounds and methods for inhibiting mitotic progression
08/09/2007CA2635814A1 Amido compounds and their use as pharmaceuticals
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007EP1069127B1 Microencapsulated lewis acid
08/08/2007CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase
08/08/2007CN101012229A Hanfangchin A without benzene and chloroform and preparing method thereof
08/08/2007CN101012196A Fragrant geldanamycin derivative and its preparing method and use
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253180 Viricides; immunology moderator
08/07/2007US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives
08/07/2007CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction
08/02/2007WO2007087204A2 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia
08/02/2007WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
08/02/2007WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS
08/02/2007US20070179167 Inhibitors of serine proteases
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070179129 Opioid receptor antagonists
08/02/2007CA2637717A1 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia
08/01/2007EP1813617A1 PROCESS FOR PRODUCING BENZOÝc¨PHENANTHRIDINE DERIVATIVE
08/01/2007EP1813616A2 Pyrazoloquinolines with immunomodulating activity
08/01/2007EP1812443A2 [3.2.0] heterocyclic compounds and methods of using the same
08/01/2007EP1812404A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
08/01/2007EP1812113A1 Pyrimidine compounds as histamine modulators
08/01/2007EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
08/01/2007EP1255759B1 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
08/01/2007CN1329395C Tricyclic imidazopyridines
08/01/2007CN101008023A Technology for extracting dihydrogalanthamine from lycoris radiata genus plant
08/01/2007CN101007809A Water-soluble camptothecine derivative and its preparation process and application thereof
08/01/2007CN101007808A Process for preparing superfine camptothecine
08/01/2007CN101007807A 6-cyano-1,1(1,3-subpropyldioxy)-7-[1'-(carbalkoxy)-propyl]-5-oxo-delta6(8)-tetrahydro indolizine compound preparation method
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same
07/31/2007US7250438 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams
07/31/2007US7250426 acid addition salt of optionally substituted 5-[2-(indan-2-ylamino-1-hydroxyethyl)]-8-hydroxyquinolone; treating respiratory disorders, especially asthma and COPD
07/31/2007US7250424 Fab I inhibitors
07/31/2007US7250423 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers
07/31/2007US7250413 C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
07/31/2007US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
07/31/2007US7250409 Ningalin B analogs employable for reversing multidrug resistance
07/31/2007CA2215633C Oxidative process for preparing narwedine derivatives
07/26/2007WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders
07/26/2007WO2007040650A9 Apoptosis promoters
07/26/2007WO2007021674A3 Method of acylating maytansinol with chiral amino acids
07/26/2007WO2006127588A3 Modulators of atp-binding cassette transporters
07/26/2007US20070173642 Process for the purification of macrolides
07/26/2007US20070173640 Ionic liquid type crown ether derivatives, method for preparing the same and method for isolating metal ions using the same
07/26/2007US20070173570 polystyrene polymerization activator; 7,7,9,9-Tetramethyl-8-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,4-dioxa-8-aza-spiro[4.5]decane; or 3,3,8,8,10,10-Hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza -spiro[5.5]undecane
07/26/2007US20070173507 Dairyl-substituted five-membered heterocycle derivative
07/26/2007US20070173495 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
07/26/2007US20070172951 Time-temperature indicator based on valence isomerizations
07/26/2007US20070172420 Ligands
07/26/2007CA2637385A1 Compounds for the treatment of inflammatory disorders
07/26/2007CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders
07/25/2007EP1809635A1 2,6-diethyl-4-methyl-phenyl-substituted tetramic acid derivatives
07/25/2007EP1809634A1 2-alkoxy-6-alkyl-phenyl-substituted spirocyclic tetramic acid derivatives
07/25/2007EP1809605A1 Quinoline as allosteric enhancers of the gaba-b receptors
07/25/2007CN101006055A 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon
07/25/2007CN101005840A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
07/25/2007CN101003556A Derivative of 10 ¿C hydroxyl camptothecin, prepartion of its liposome, and preparation method
07/25/2007CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
07/25/2007CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247648 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
07/24/2007US7247634 Rifamycin derivatives effective against drug-resistant microbes
07/24/2007US7247629 Antitumoral analogs of et-743
07/24/2007US7247628 Cannabinoid receptor ligands and uses thereof
07/24/2007CA2311476C Dibenzorhodamine dyes useful as florescent labelling agents
07/19/2007WO2007081690A2 Inhibitors of protein kinases
07/19/2007WO2007079862A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
07/19/2007WO2007079861A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
07/19/2007WO2007079830A1 Oxaphenanthrene derivatives
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES